Iliac Stent Global Market Report 2024

The iliac stent market size has grown strongly in recent years. It will grow from $0.95 billion in 2023 to $1.02 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The expansion observed during the historical period can be attributed to several factors, including the growth of the global healthcare industry, increased awareness about minimally invasive procedures, rising demand for stenting procedures, an increase in the incidence of iliac artery diseases, and improvements in healthcare infrastructure.

The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.34 billion in 2028 at a compound annual growth rate (CAGR) of 7%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing prevalence of peripheral artery diseases, the growing geriatric population, rising angioplasty procedures, a heightened demand for less invasive interventions, and the increasing incidence of diabetes. Key trends expected in the forecast period encompass technological advancements in iliac stents, a growing number of product approvals, advancements in medical technology, the expansion of distribution networks, and the adoption of iliac stents in outpatient settings for enhanced patient convenience and accessibility.

The increasing incidence of peripheral artery diseases is anticipated to drive the expansion of the iliac stent market in the foreseeable future. Peripheral artery disease (PAD) is a vascular condition characterized by the narrowing or blockage of arteries outside the heart and brain, often attributed to factors such as smoking, an aging population, hypertension, and diabetes. Iliac stenting emerges as a valuable treatment modality for PAD patients, offering enhanced blood flow, relief from symptoms, and mitigation of complications, all while being minimally invasive and boasting a high success rate. For instance, as per data from the Society for Cardiovascular Angiography and Interventions in July 2023, PAD affects 8-10 million Americans annually, with projections estimating 19 million Americans to be affected by PAD by 2050. Hence, the escalating prevalence of peripheral artery diseases serves as a driving force for the iliac stent market.

Key players in the iliac stent market are dedicated to innovating products such as iCast to elevate patient outcomes and diminish the likelihood of complications. The iCast-covered stent system signifies a novel approach to addressing iliac artery occlusive disease, offering superior performance and a reduced risk of complications compared to conventional bare-metal stents. For instance, in October 2023, Getinge announced the US commercial availability of the iCast-covered stent system, FDA-approved for treating iliac arterial occlusive disease. This development underscores Getinge's commitment to furnishing US clinicians and hospital systems with top-tier products and support for managing this critical condition effectively.

In February 2023, Abbott Laboratories finalized the acquisition of Cardiovascular Systems Inc. (CSI) for an undisclosed sum. This strategic move by Abbott Laboratories aims to enrich its vascular device portfolio by integrating CSI's innovative atherectomy system. Cardiovascular Systems Inc. is renowned for its contributions in the realm of medical technology, particularly in manufacturing iliac stents.

Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH.

North America was the largest region in the iliac stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the iliac stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Iliac stents are specialized medical devices crafted to address atherosclerosis in the iliac arteries, situated in the pelvic region. These stents are deployed through minimally invasive procedures such as angioplasty to widen and provide support to narrowed or obstructed arteries.

The primary types of iliac stents include self-expandable stents, balloon-expandable stents, and others. Self-expandable stents are medical instruments utilized for treating narrowed or obstructed blood vessels in various parts of the body, including the coronary arteries, peripheral arteries, and other tubular structures. They are employed in the treatment of various artery lesions such as common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. These stents are utilized by a range of end-users including hospitals, outpatient facilities, and others.

The iliac stent market research report is one of a series of new reports that provides iliac stent market statistics, including iliac stent industry global market size, regional shares, competitors with an iliac stent market share, detailed iliac stent market segments, market trends, and opportunities, and any further data you may need to thrive in the iliac stent industry. This iliac stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iliac stents market consists of sales of coronary stents, biliary stents, and ureteral stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.